论文部分内容阅读
布洛芬系非甾体类解热镇痛药,由于它的镇痛效果较好,不良反映轻微.常用予治疗风湿类疾病、芬必得为布洛芬的缓释剂型.在药理学上具有血浓度相对稳定的特点.故在提高疗效和降低不良反映方面.优于普通剂型的布洛芬。有人在治疗非关节性风湿类疾病时.将两种剂型做了比较。将病人随机分三组。第一组组芬必得600mg,每日2次于进餐同时服下;第二组芬必得1200mg.晚间一次与饭同服;第三组用布洛芬400mg,每日三次餐时服.疗程均为3个月.结果表明服用芬必得的两组病人其症状改善优于布洛芬组.特别在减轻疼痛、提高睡眠质量、总体评价方面尤为突出.具有显著性差异.在不良反应方面.第一组的不良反应
Ibuprofen is a non-steroidal antipyretic analgesic, because of its analgesic effect is good, mild adverse reactions. Commonly used to treat rheumatic diseases, Fenbid is a sustained-release form of ibuprofen pharmacologically Blood concentration is relatively stable features, it is to improve the efficacy and reduce adverse reactions, superior to the ordinary dosage form of ibuprofen. Some people in the treatment of non-joint rheumatism disease when the two formulations were compared. The patients were randomly divided into three groups. The first group of Fenbid 600mg, 2 times a day at the same time taking the meal; the second group Fenbid 1200mg. Dinner with the same meal at night; the third group with ibuprofen 400mg, three meals daily service. For 3 months.The results showed that the two groups of patients taking Fenbid in the improvement of symptoms better than the ibuprofen group.Especially in relieve pain and improve sleep quality, the overall evaluation is particularly prominent.With significant differences in adverse reactions, the first A group of adverse reactions